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Vasomotility of normal and stenosed coronary arteries
was studied at rest and during supine bicycle exercise
in 10patients with classicalexercise-inducedangina pec-
toris receiving 1 mg intracoronary propranolol before
the exercise test (propranolol group). Normal and ste-
notic coronary lumen areas were determined from bi-
plane coronary arteriograms using a computer-assisted
system. Measurements were performed at rest, after 1
mg intracoronary propranolol, during supine exercise
(89 W for 3.4 minutes) and 5 minutes after 1.6 mg sub-
lingual nitroglycerin administered at the end of the ex-
ercise test. The results were compared with previously
obtained data on the effect of dynamic exercise on coro-
nary lumen area in 12 patients receiving no medication
(control group) and in 6 patients receiving0.1 mg intra-
coronary nitroglycerin before the exercise test (nitro-
glycerin group).
In the control group, coronary stenosis area de-
creased during exercise to 71% of levels at rest (p <
0.001) whereas normal coronary lumen area increased
to 123% of control (p < 0.01). In the propranolol group
both normal (113%, p < 0.05 versus rest) and stenotic
coronary lumen area (122%, p < 0.05 versus rest) in-
creased during exercise. A similar increase in both nor-
Beta-adrenergic blocking agents are frequently used to treat
patients with coronary artery disease, hypertension and car-
diac arrhythmias. The beneficial effect of these agents in
ischemic heart disease has been attributed to a reduction in
myocardial oxygen consumption produced by a reduction
in left ventricular contractility, heart rate and afterload.
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mal and stenotic areas was observed during exercise
after pretreatment with 0.1 mg intracoronary nitro-
glycerin (123%, p < 0.01 and 114%, p = NS versus
rest). Sublingual administration of 1.6 mg nitroglycerin
at the end of exercise increased coronary stenosis area
to 145% (p < 0.01 versus rest) in the propranolol group
and to 115% in the control group (p = NS versus rest).
It is concluded that intracoronary administration of
propranolol does not potentiate coronary vasoconstric-
tion of the epicardial vessels at rest and during exercise.
In contrast, intracoronary propranolol prevents exer-
cise-induced stenosis narrowing either 1) because of re-
duced myocardial oxygendemand with a lower coronary
blood flow resulting in a smaller transstenotic pressure
gradient and, thus, a smaller flow-induced fall in stenosis
distending pressure; or 2) because of "local" beta-
receptor blockade with unopposed distal arteriolar al-
pha-receptor tone, resulting in a higher poststenotic
pressure and, thus, in a greater stenosisdistending pres-
sure; or 3) because of a local anesthetic effect of pro-
pranolol with a decrease in calcium influxto the coronary
smooth musculature.
(J Am Coil CardioI1987;JO:299-310)
Coronary artery spasm has been shown to occur in patients
with Prinzmetal's variant angina pectoris (1,2). Abnormal
coronary vasomotor tone with decreases in coronary blood
flow has been reported not only in variant angina but also
in classical and unstable angina pectoris (3,4). Gage et al.
(5) recently demonstrated that in stenotic coronary arteries
vasoconstriction may occur during dynamic exercise, whereas
normal coronary arteries show vasodilation during exercise.
This vasoconstriction was attributed to a local phenomenon
due either to a passive collapse (Venturi mechanism) of the
normal vessel wall of an eccentric coronary stenosis or to
malfunction of the endothelium with a lack of the endothe-
lium-derived vasorelaxing factor.
Animal and human studies (6-11) have shown that coro-
nary artery vasoconstriction and increases in coronary vas-
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cular resistance can be induced by sympathetic stimulation
after beta-adrenergic blockade; in patients with variant an-
gina, exacerbation of coronary spasm after beta-adrenergic
blockade has been reported (1,12,13). These vasoconstric-
tive reactions contrast with the well documented beneficial
effect of beta-blocking agents in the treatment of patients
with classical angina pectoris in whom adverse reactions
with potentiation of myocardial ischemia are rare. Thus, the
purpose of the present study was to evaluate the effect of
intracoronary propranolol on normal and stenotic coronary
artery dimensions at rest and during dynamic exercise in
patients with coronary artery disease and classical, exercise-
induced myocardial ischemia.
Methods
Study patients. Ten patients with coronary artery dis-
ease and exercise-induced myocardial ischemia were in-
cluded in the present study; their mean age was 50 years
(range 37 to 69). Six had a history of myocardial infarction.
Patients were selected on a consecutive basis when the fol-
lowing inclusion criteria were fulfilled: 1) a history of stable
effort-related angina pectoris (n = 9) or signs of exercise-
induced ischemia with ST segment depression (n = 9), or
both; and 2) coronary artery stenosis clearly visible on an-
giography for quantitative assessment. No patient had ST
segment elevation during dynamic exercise or a history of
angina pectoris at rest. All patients performed a precathe-
terization upright bicycle exercise test while on their usual
medical regimen. Ten were receiving a beta-blocker, 9 a
long-acting nitrate and 6 a calcium blocker. All drugs were
discontinued at least 12 to 24 hours before the catheteriza-
tion.
Cardiac catheterization. Patients underwent right and
left heart catheterization in the fasting state. Informed con-
sent was obtained from all patients. Premedication consisted
of 10 mg chlordiazepoxide administered orally I hour before
catheterization. Aortic pressure was measured with a Jud-
kins catheter introduced through the right femoral artery.
Pulmonary artery pressure was measured with a 7F pacing
catheter with a side lumen for pressure recordings introduced
through the right femoral vein. A standard lead of the routine
electrocardiogram (ECG) was monitored in all patients at
rest and during exercise. Aortic and pulmonary pressure,
cinemarkers for the right and left anterior oblique projections
and ECG were recorded at a paper speed of 150 mm/s
(Electronics for Medicine, model VR-12) at rest and during
exercise coronary arteriography. Simultaneous biplane coro-
nary arteriography was performed in the 30° right anterior
oblique and 60° left anterior oblique projections at a filming
rate of 50 frames/so
Study protocol. First, routine left ventricular biplane
angiocardiography was performed; then biplane coronary
arteriography of the right and left coronary arteries was
carried out for diagnostic purposes. Four patients had one
vessel disease, one patient had two vessel disease and five
patients had three vessel disease. Control biplane arteri-
ography of the left coronary artery (n = 10) was carried
out in the right and left anterior oblique projections for
quantitati ve assessment. An interval of at least 10 minutes
passed between the last diagnostic coronary arteriogram and
the baseline coronary arteriogram for the exercise study.
Aortic and pulmonary artery pressures were recorded im-
mediately before coronary arteriography. Subsequently, the
patient's feet were secured to a bicycle ergometer (Siemens-
Elema AB, model 380 B). Then propranolol, I mg, was
injected over 3 to 4 minutes into the left coronary artery.
Biplane coronary arteriography was repeated 5 to 6 minutes
after initiation of the injection. Then, exercise was begun
at a level of 50 to 75 W, which was increased every 2
minutes in increments of 25 to 50 W. Repeat biplane coro-
nary arteriography with concurrent aortic and pulmonary
artery pressure recordings was performed each minute and
at the end of exercise (Fig. 1). Intracatheterization exercise
was terminated because of anginal pain in six patients and
fatigue in four. Sublingual nitroglycerin, 1.6 mg, was given
immediately at the end of exercise, with coronary arteri-
ography repeated at 5 minutes thereafter, when pain had
already subsided. There were no complications related to
the procedure.
Quantitative coronary arteriography. Moderate to se-
vere coronary artery stenoses as well as normal vessel seg-
ments of the left coronary system were chosen for analysis
(Fig. I). In each patient, a stenosis that could be easily
identified with no superposition of other vessels or structures
was selected for quantitative analysis. Stenosis of the left
anterior descending artery was analyzed in seven patients,
of the left circumflex artery in two and of the ramus inter-
medius in one patient. The normal vessel segment was se-
lected from a disease-free vessel when possible (n = 5);
otherwise an uninvolved prestenotic vessel segment (n =
5) was chosen at least four catheter-widths (4 x 2.5 mm
= 10 mm) from the center of a stenosis that was not used
for quantitative analysis. A normal vessel segment of the
left anterior descending artery or of its diagonal branch was
analyzed in two patients and of the left circumflex artery or
of its major branch in seven patients. The left main coronary
artery was used in one patient. No direct evidence was
obtained by left ventricular angiocardiography that the sten-
osed vessel selected for quantitative assessment caused isch-
emia during exercise. However, four patients had one vessel
disease and in the remaining six patients the most prominent
and most severe stenosis was chosen for quantitative anal-
ysis to obtain meaningful data with regard to exercise-in-
duced myocardial ischemia. In one patient, collateral vessels
were observed from the right coronary artery to the left
anterior descending coronary artery.
The angiographic films were projected (Vanguard In-
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Figure l. Case 2. Exercise coronary arteriography in a 39 year
old man with a history of exercise-induced angina pectoris with
ST segmentdepressionof 0.25 mYduring uprightbicycleexercise.
Coronary arteriography at rest (upper panel) showed severe ste-
nosis of the left anterior descending coronary artery (one vessel
disease). Coronary stenosis remained unchanged after intracoro-
nary injectionof I mg propranolol (middle panel; 0.5 versus 0.5
mrrr' at rest) and increased slightly to 0.57 mnr' at peak exercise
(lower panel). Exercisewasterminated becauseof anginapectoris.
Mean pulmonary pressure increasedfrom 19 rnm Hg at rest to 3X
rnm Hg during peak exercise.
strument Corp., model XR35) on a screen to a size ap-
proximately 2.5 x normal. Tracings were then made from
those simultaneous left and right anterior oblique frames
that best visualized the stenosis or normal vessel segment.
All vessel segment analyses were performed in a blinded
fashion. The arteriogram was projected and the tracings
were made on white paper by an observer unaware of the
particular study conditions, that is, control, propranolol,
exercise or nitroglycerin. Stenosis tracings also included
arteriographically normal vessel segments both proximal
and distal to the stenosis. The arteriograms were traced at
the same time in the cardiac cycle for a given patient usually
during mid- or end-diastole. Because four to six frames were
analyzed for each vessel segment, two or three frames were
traced during the same diastolic filling phase. Systolic-di-
astolic variations in epicardial vessel diameter have been
reported in the experimental animal (8,9) to be in the range
of 3 to 5%. These small changes in vessel diameter are
clearly below the resolution of the angiographic technique
and cannot be detected by quantitative coronary arteriog-
raphy. A section of the catheter of known dimension was
traced as a scaling factor (14). By filming a grid at the
conclusion of each study, pincushion distortion was found
to be small for our system; measurements made at the pe-
riphery varied by < 1.3% from those made at the center.
Therefore, no correction was made. The stenoses were then
traced on a digitizer (Numonics Corp.) linked to a PDP
11/34 computer.
The computer program [or quantitative analysis of coro-
nary arterv stenosis has been described previously (5,/4).
A three-dimensional model of the vessel segment was con-
structed from the biplane tracings. The proximal and distal
as well as minimal cross-sectional areas of the vessel seg-
ment were calculated by the computer. Normal vessel area
represents the average of the proximal and distal measure-
ments. Percent stenosis was calculated from the stenosis
minimal cross-sectional area divided by the average of the
areas of the proximal and distal ends of the stenotic segment.
For each vessel segment, four to six frames were analyzed
and the results expressed as the mean.
When difficulties were encountered in visualization of
the stenosis in one of the biplane views because of overlying
vessels (contrast reflux into the aorta, n = 4) or because
the analyzed vessel was orthogonal to one of the two pro-
jections, (n = 4), a single view was used. In these cases
(two normal and six stenosed vessels), the computer con-
structed a circular lumen to calculate the cross-sectional
area. These findings are comparable with the data reported
by Brown et al. (15), in which 24% of all stenoses (versus
40% in our study) were visualized sufficiently to use biplane
analysis.
Validation of quantitative coronary arteriography.
Quantitative coronary arteriography has been shown to be
a reliable tool for quantification of coronary artery stenosis
(14,16). Interobserver and intraobserver variability has been
evaluated in our laboratory (5) in 10 patients with coronary
artery disease for monoplane and biplane measurements (Fig.
2). Eleven normal and II stenotic vessel segments were
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for observer I and 0.48 mrrr' for observer 2 (12.3 and
12.5%, respectively, of the mean biplane vessel area). Re-
peated measurements of the same vessel segment showed a
good reproducibility with a mean SO of 6% of the mean
biplane vessel area. When more severely stenotic segments
«2.5 mnr') were traced, the SO of the mean biplane vessel
area increased to 8%.
Further validation of quantitative coronary arteriography
included measurement of a stenosis of 1.6 mrrr' cross-sec-
tional area machined from a stainless steel rod of 6.8 mm?
area. The stenosis and a coronary catheter of known di-
mension were suspended in water and placed on the cath-
eterization table at the same position as a patient's heart
during the exercise study. A film was made and analyzed
in the same fashion as for a coronary stenosis. The calculated
area of the stenotic region was 1.6 mm? and of the adjacent
rod 6.7 mm", representing an error of 0 and 1.5% from the
control measurements, respectively.
Effect of repeated contrast dye injections on coronary
luminal area. Because intracoronary injection of contrast
medium (5 to 7 ml amidotrizoate [Urografin-76%]) might
be associated with coronary vasodilation, the effect of coro-
Figure 3. Effect of contrast medium. Percent changes in normal
coronary vessel area during repeated intracoronary injections of 3
to 5 ml of amidotrizoate (Urografin-76%). Intracoronary injections
at intervals of I minute are not associated with a change in coronary
lumen area. After sublingual administration of 1.6 mg nitroglyc-
erin, there is a progressive rise in coronary lumen area that becomes
significant 3 minutes after sublingual application. C = control
(rest).
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Figure 2. Interobserver variability for monoplane and biplane
quantitative coronary arteriography. In 10 patients with coronary
artery disease, II normal and II stenotic vessel segments were
traced by two independent observers. Correlations were excellent
between the two observers and the SEE of the mean vessel area
was 9.3% for monoplane and 7.9% for biplane measurements.
There was also an excellent correlation between monoplane and
biplane data (r = 0.979 for observer 1 and 0.978 for observer 2).
traced by two independent observers, and coronary vessel
diameter was calculated using our computer program for
quantitative analysis of coronary artery stenosis (14). The
correlation (Fig. 2) for monoplane (r = 0.992) and biplane
(r = 0.991) measurements was excellent and the SEE was
0.39 rnrrr' (9.3% of the mean vessel area) for monoplane
and 0.30 mrrr' (7.9% of the mean vessel area) for biplane
coronary arteriography. The correlation between monoplane
and biplane data (r = 0.979 for observer I and 0.978 for
observer 2) was also excellent and the SEE was 0.47 mm?
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nary arteriography on normal coronary luminal area was
studied in five patients with (n = 4) or without (n = I)
coronary artery disease (Fig. 3). Intracoronary injections
were performed at intervals of I minute, five times under
rest conditions and five times after sublingual administration
of 1.6 mg nitroglycerin. There was absolutely no change in
coronary luminal area after repeated intracoronary injections
of contrast medium; however, after sublingual nitroglycerin
there was a mild increase in coronary luminal area as early
as I and 2 minutes after administration and a significant
increase 3 minutes after sublingual application of nitro-
glycerin (Fig. 3). It is well known from previous studies
(17) that intracoronary injection of contrast medium is ac-
companied by a brief increase in coronary blood flow be-
cause of the effect of the medium on the small resistance
vessels. Generally flow returns to control levels 30 to 60
seconds after injection (17, 18).
Statistical analysis. The hemodynamic and arterio-
graphic data in response to propranolol and exercise, ex-
pressed in absolute values and in percent of control, were
compared by a two-way analysis of variance for repeated
measures. When data before and during catheterization were
compared, a paired t test was used. Data from this study
were also compared with our previously published data (5)
using a one-way analysis of variance (control, propranolol
and nitroglycerin groups). If the analysis showed a signif-
icant difference, the Scheffe procedure was applied. In the
tables, mean values ± I SO, and in the figures. mean values
± I SE are reported.
Results
Clinical data. The mean functional class of the 10 pa-
tients (New York Heart Association criteria) was 1.9 ± 0.5
and their ejection fraction was 59 ± 13%.
Exercise capacity. The response to baseline upright bi-
cycle and to intracatheterizationsupine bicycle exercise test-
ing is presented in Table I. The patients achieved a mean
work load of 134 W during the upright test (82%) and of
89 W (53% of their predicted work capacity) during the
supine bicycle stress test (p < 0.(01). The maximal achieved
mean heart rate was 131 and 109 beats/min, respectively.
Table 1. Baseline Upright Bicycle Exercise Versus lntracatheterization Supine Bicycle Exercise Test
Patient No. WL II<. HR BP RPP ST
A. Upright Bicycle Exercise
I 100 6LJ III 2051100 227 0.3
2 120 72 III I55/LJO 172 0.25
3 150 101 14X 145/90 210 0.1 X
4 100 67 157 140/90 21LJ 0.9
5 200 1m 124 17011 00 21X 0.3
6 210 100 175 100/XO 175 0.4
7 SO 52 114 115/S0 131 037
X 120 100 131 IXO/IOO 235 0
LJ ILJO 110 137 ILJ5/105 267 0.26
10 70 47 110 150/95 165 0.25
Mean 134 X2 131 155m 202 0.32
±SD 50 23 22 33/X 40 0.23
B. Supine Bicycle Exercise
I 75 52 X2 157/65 12X
2 100 60 117 I 29/XO 150
3 100 67 120 IX0I5X 216
4 70 45 120 122176 146
5 150 75 114 15X/LJO IXO
6 125 5LJ 130 X7/42 113
7 50 32 LJX 1451100 142
X 50 41 76 135/XO 102
9 125 72 113 122175 137
10 50 34 125 125/60 156
Mean XL)t 53+ 109* 1361721 1471'
±SD 36 15 IX 25116 32
T
A
A
F
A
A
F
A
A
F
A
7110
A
A
F
A
F
F
A
A
F
A
6/10
Comparison of supine bicycle exercise with upright bicycle exercise: *p < (U)2; tp < {U)l; +p < 0.001. A = angina pectoris; BP = systolic and
diastolic blood pressure for upright and systolic and diastolic aortic pressure for supine bicycle exercise (mm Hg): F = fatigue; HR = heart rate
(beats/min); % = work load in percent of predicted physical working capacity (from sex. age and height); RPP = heart rate-systolic blood pressure
product (mm Hg x loo/min); ST = ST segment depression (rnv) during upright bicycle exercise; T = reason for tcrmination of exercise test; WL =
work load at maximal exercise (W).
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Table 2. Hemodynamic Response to Supine Bicycle Exercise
Mean Aortic Pressure Mean Pulmonary Artery Pressure
Patient Heart Rate (beats/min) (mm Hg) (mmHg)
No. R PR Ex NTG R PR Ex NL R PR Ex NTG
I 49 53 82* 61 110 109 105* 100 24 27 51* 21
2 56 53 117* 60 90 98 99* 79 19 15 38* 16
3 84 75 120 90 III 124 76 101 14 16 46 20
4 51 52 120* 90 97 101 96* 94 28 34 58* 28
5 46 50 114 68 88 95 III 76 17 25 37 38
6 80 75 130 90 81 75 70 61 12 13 19 12
7 75 66 98* 74 101 94 98* 101 13 22 47* 13
8 56 63 76* 60 94 97 95* 100 23 30 45* 28
9 87 77 113 82 113 105 90 95 14 19 38 9
10 73 79 125* 70 90 89 92* 82 13 17 38* 10
Mean 65 64 109t 74 97 98 93 89 17 22 4It 19
±SD 15 II 17 12 II 12 12 13 5 7 10 9
*Angina pectoris. t Signiricance versus rest values: p < 0_00 I. Ex = peak supine bicycle exercise; NTG = sublingual nitroglycerin given at the end
ofexercise: PR = intracoronary propranolol; R = rest.
The mean heart rate-systolic blood pressure product was
20,200 mm Hg/min during the upright bicycle exercise test
and the mean heart rate-systolic aortic pressure product 14,700
mm Hg/min during the supine test (p < 0.00l). Exercise
was terminated because of angina in 7 of the 10 patients
during the precatheterization exercise test and in 6 of the
10 patients during the intracatheterization test.
Hemodynamic data. The responses of heart rate and
mean aortic and mean pulmonary pressure to propranolol
and exercise are presented in Table 2. Heart rate and mean
aortic and mean pulmonary pressure did not change after
intracoronary propranolol (Fig. 3). Two patients had a heart
rate <50 beats/min at rest although the beta-blocker had
been withdrawn >24 hours before the study; both patients
had already manifested bradycardia at the first ambulatory
clinical examination 3 and 6 weeks, respectively, before
catheterization. During exercise, heart rate increased from
65 to 109 beats/min (p < 0.00 I) whereas mean aortic pres-
sure dropped slightly but mean pulmonary artery pressure
increased from 17 to 41 mm Hg (p < 0.00 I) and decreased
toward rest levels after administration of sublingual nitro-
glycerin at the end of the exercise study (Fig. 4).
Quantitative arteriography. A representative case with
coronary arteriograms of a stenotic coronary artery at rest,
after intracoronary propranolol and during dynamic exercise
is shown in Figure I. Individual data for the 10 patients are
presented in Table 3 and Figure 5. A small, insignificant
increase in both normal (106%) and stenotic (118%) coro-
nary vessel areas was observed after propranolol. During
maximal exercise coronary artery lumen area increased sig-
nificantly in the normal vessel segment (113%, p < 0.05
for absolute and percent changes) (Fig. 6) and stenotic vessel
segment (122%, p < 0.09 for absolute and p < 0.05 for
percent change) (Fig. 5 and 7). There were some variations
in coronary lumen area of the normal and stenotic vessel
segments after propranolol and during exercise but there
was a definite trend to increased coronary lumen area in
Figure 4. Changes in mean aortic pressure (AoP) and mean pul-
monary artery pressure (PAP) during exercise (control group) and
after intracoronary pretreatment with nitroglycerin (nitroglycerin
group) or propranolol (propranolol group). In the control group
both aortic and pulmonary artery pressure increased significantly
during exercise, whereas inthenitroglycerin and propranolol groups
aortic pressure remained unchanged butpulmonary artery pressure
increased significantly during exercise. Mean pulmonary artery
pressure during exercise was significantly lower (p < 0.05) in the
nitroglycerin than in the control group, probably because of the
anti-ischemic and venodilating effect of nitroglycerin.
_CONTROL
0- ONITROGLYCERIN
110 • -.PROPRANOLOL
100
AoP
90 ~
80
C;; 70::z::
E
E- 60
u.J
c=
::> 50
""
"" **u.Jc= 40
-*-*+Q..
.: ~.
30 /,< Q - - -, '\ PAP, / -,
+.~:--&'/ / -,20
'"10 ?MEAN±l SEM * P ·001 Cvs.
* *
P • 0.001
0 I.C 2 minEx max.Ex NTG
lACC Vol. 10, No, 2
August 19~7 : 299-310
GAGLIONE ET AI..
CORONARY VASOMOTION AFfER BETA-BLOCKADE
305
Table 3. Luminal Area of Normal and Stenotic Coronary Artery Segments in Response to Propranolol, Dynamic Exercise and
Sublingual Nitroglycerin
Patient Normal Vessel Irnrrr') Stenosis (mm-)
No, R PR Ex NTG R PR Ex NTG
7,30 8,30 12,20 12,20 LlO 1.80 1.33 1,70
2 5 ,OS 5,2 0 6AO 6 AO 0,50 0, 50 0 ,57 O,SO
3 11.60 11.60 11.60 15.00 0 .6X 0 .68 0.74 0.76
4 5,10 5, 10 4.73 7.00 UO 2,10 1.50 2,00
5 8,00 S,50 X.IO 'J.20 1.2X 1.28 U6 U5
6 11.70 10,00 'J.70 13.00 2.20 2,70 3.IX) 4 .10
7 4A6 5. 10 5.55 6.'JO O.'JO O,'JO 0 .90 O.'JO
8 5.!Xl 5, 30 5.10 5.X3 0.50 0 .60 1.(Xl 1.!Xl
9 2. 10 2,37 1.'J2 2.31 0 .63 0 .70 0 .60 0.'J7
10 5.12 5,20 5.XO 6.20 1.10 1.12 \.53 1.50
Mean 6.24 6,66 7. 11* 8.4lH* 1.01 1.23 1.25 i.so:
:!: SD 2.60 2,80 3.2 4 3,SO 0 .50 0 .73 0.7 1 1.00
Significance versus rest values: *p < 0 ,05 ; t p < 0,01; +P < O.OOl: versus exercise values: *P < 0.05 . Abbreviations as in Table 2.
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Figure S. Changes in coronary stenosis area during exercise after
intracoronary pretreatment with I mg propranolol (PR), There is
a mild increase in stenotic area in 5 of the 10 patients after intra-
coronary injection of propranolol. After 2 and 4 minutes of ex-
ercise. stenotic areaincreased more than 10% in6 of the 10 patients
(p < 0,05 versus rest) but remained more or less unchanged
(p = NS) in 4 paents. This corresponds to the anatomy of the
stenosis (eccentric or concentric) because vasodilation can occur
only in the presence of a normal vessel segment within thestenotic
coronary circumference, After sublingual nitroglycerin (NTG).
coronary stenosis area further increased (p < 0,01 versus rest) in
the six patients with vasodilation during exercise but remained
unchanged (p = NS) in the four patients with no change in coro-
nary lumen area during exercise . C = control (rest) .
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both the normal segment (8 of 10 patients after intracoronary
propranolol and 7 of 10 patients during exercise) and the
stenotic segment (6 of 10 patients after intracoronary pro-
pranolol and 8 of 10 patients during exercise); in contrast.
(5) all 12 patients in our previous study showed a decrease
in coronary stenosis area during exercise. Five minutes after
sublingual nitroglycerin the normal segment (13 1%, P <
0.001 for absolute and percent change) and stenotic vessel
segment (145%, p < 0.01 for absolute and percent change)
showed a significant increase in vessel area (Fig. 6 and 7),
When these data are compared with those previously
obtained (5), the behavior of the normal vessel of the present
study after propranolol was similar to that of the normal
vessel of the untreated patients (control group) during ex-
ercise (Fig, 6), After 0.1 mg intracoronary nitroglycerin
(nitroglycerin group), coronary vasodilation occurred, which
was significantly (p < 0.0 I) greater than vasodilation con-
sequent to intracoronary propranolol. However, during ex-
ercise the normal vessel dilation was similar in the three
groups although it was smallest in the propranolol group
(Fig. 6). The behavior of the stenotic vessel after propran-
olol was completely different during exercise from that of
the untreated control group (Fig. 5 and 7). There was va-
soconstriction of the stenotic segment in the untreated group
during bicycle exercise , whereas vasodilation occurred dur-
ing exercise after pretreatment with propranolol or nitro-
glycerin (Fig. 5 and 7). After sublingual nitroglycerin all
three groups exhibited vasodilation of the stenotic coronary
vessel segment.
Discussion
C 1 2 3 4
l- EXE RCISE _ .J
G
Factors determining corona ry flow. Regional coronary
blood now is determined by several factors such as perfusion
pressure, coronary vascular resistance. metabolic demands
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creases in beta-adrenergic tone have been associated with
coronary artery vasodilation (25), whereas the precise effect
of beta-adrenergic blockade on coronary vascular tone in
humans is not yet clearly defined (11).
Effect Of Propranolol on Coronary Lumen Area
at Rest
Normal coronary artery. In our study, intracoronary
injection of I mg propranolol was associated with a small
and insignificant increase of the cross-sectional area of nor-
mal coronary artery segments in 10 patients with coronary
artery disease (Fig. 6). The hemodynamic determinants of
myocardial oxygen consumption remained unchanged be-
fore and after intracoronary injection of propranolol sug-
gesting no secondary effect on coronary lumen area. There
was no vasoconstrictive effect on normal coronary arteries
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Figure 7. Percent changes in coronary stenosis area during ex-
ercise (control group) and after intracoronary (I.C.) pretreatment
with nitroglycerin or propranolol. Coronary stenosis area decreased
significantly during exercise (Ex) in the control group. However,
coronary vasodilation of the stenotic segment was observed after
intracoronary injection of nitroglycerin with no further increase (p
< 0.001 at 2 minutes and at peak exercise versus control group)
in stenosis area during exercise. Intracoronary injection of pro-
pranolol eliminated coronary stenosis narrowing during exercise
(p < 0.001 at 2 minutes and at peak exercise versus control group;
p = NS versus nitroglycerin group). Administration of sublingual
nitroglycerin at the end of the exercise test further dilated (p <
0.05 versus peak exercise) coronary stenoses after pretreatment
with propranolol, suggesting an additive mechanism between pro-
pranolol and nitroglycerin (p < 0.05 versus control and p = NS
versus nitroglycerin group).
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Figure 6. Percent changes in normal coronary vessel area during
exercise (control group) and after intracoronary (1.C.) pretreatment
with nitroglycerin (nitroglycerin group) or propranolol (propran-
olol group). The control and propranolol groups showed a similar
behavior during exercise (Ex) with coronary vasodilation at peak
exercise and after sublingual administration of 1.6 mg nitroglycerin
(NTG) at the end of the exercise test. However, vasodilation was
slightly less (p = NS) at peak exercise in the propranolol than in
the control group probably because of reduced metabolic demands
due to administration of the beta-blocking agent (for further ex-
planation see text). Intracoronary injection of nitroglycerin was
associated with maximal coronary vasodilation (p < 0.01 versus
intracoronary propranolol) with no further dilation during exercise
(after 2 minutes of exercise, p < 0.05 versus control, p = NS
versus propranolol group; at peak exercise, p = NS versus control
and propranolol groups). Administration of sublingual nitroglyc-
erin (NTG) dilated normal coronary vessel segments maximally
in the control and propranolol-pretreated groups to an extent similar
to that in the nitroglycerin group (p = NS).
and vasomotor tone (19). In normal coronary arteries, blood
flow increases three to five times during physical exercise,
whereas in stenotic coronary arteries the increase in blood
flow is strongly dependent on the severity of the stenosis.
The actual regional blood flow is, however, not solely de-
termined by the luminal area but is the result of the complex
interplay of the previously mentioned hemodynamic, met-
abolic and neural factors. Several studies (6,19-24) have
established the presence of both alpha- and beta-adrenergic
receptors in animal and human coronary arteries. An in-
crease in alpha-adrenergic tone has been associated with
coronary artery vasoconstriction, whereas alpha-adrenergic
blockade has been shown to reduce attacks of variant angina
pectoris and abolish coronary vasoconstriction (13). In-
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after intracoronary injection of I mg propranolol. Similarly,
Vatner and Hintze (8) found no direct effect of beta-adre-
nergic blockade on coronary cross-sectional vessel area in
the conscious dog, Thus, the reported decrease in coronary
blood flow after beta-adrenergic blockade (11,26) might be
related not to epicardial coronary artery vasoconstriction but
to secondary effects such as decrease in heart rate and con-
tractility or an increase in peripheral coronary vascular re-
sistance. We did not observe changes in heart rate and aortic
pressure in the present study because propranolol was in-
jected into the left coronary artery, However, despite the
absence of overall hemodynamic changes, the intracoronary
injection of propranolol is likely to have caused some "lo-
cal" beta-blockade that probably resulted in a mild reduction
of regional myocardial oxygen consumption and, therefore,
a decrease in coronary blood flow. A dose of I mg pro-
pranolol was chosen for intracoronary injection because this
dose represents approximatively t/IO of the full systemic dose
(0.1 mg/kg body weight) and has no secondary effects on
global hemodynamic determinants of myocardial oxygen
consumption. A larger dose was not given in order to prevent
adverse reactions due to bradycardia or changes in general
hemodynamics.
Stenotic coronary artery. Intracoronary injection of I
mg propranolol was associated with a small, insignificant
increase in coronary stenosis area (Fig. 5 and 7) comparable
with the increase observed in normal coronary arteries. There
was, however, no vasoconstriction as had been postulated
on the basis of coronary flow measurements in stable angina
pectoris (11,26) or coronary arteriograms in variant angina
after beta-adrenergic blockade (13). It was suggested that
propranolol might potentiate coronary artery vasoconstric-
tion mediated by unopposed alpha-adrenergic vasomotor
tone (11,13,26). Vatner and Hintze (8) showed in the con-
scious dog that the predominance of unopposed alpha-ad-
renergic vasomotor tone is probably not responsible for
coronary vasoconstriction after propranolol, but that the de-
crease in coronary flow is related to changes in heart rate
and contractility. Theoretically, the hypotensive effect of
propranolol could lead to a reflex augmentation of alpha-
adrenergic activity resulting in coronary vasoconstriction.
However, Sheehan et al. (27) observed no increase in cir-
culating catecholamines after propranolol at rest and during
exercise. Thus, propranolol appears not to be associated
with a humorally mediated coronary vasoconstriction by
increased sympathetic activity.
Effect of Propranolol on Coronary Lumen Area
During Exercise
Normal coronary artery. Normal coronary arteries di-
late during dynamic exercise (5) with an increase of vessel
area to about 123% of control (Fig. 6). This is due to the
increased driving pressure, metabolically induced vasodi-
lation and the flow-dependent, endothelium-mediated vaso-
dilation (28-30). Unimpaired endothelial function seems to
be important for dilation of the epicardial coronary arteries
during increased flow states such as dynamic exercise. When
the effect of intracoronary administration of propranolol on
the vasomotion of the normal coronary vessel was evaluated
during exercise, we observed a similar behavior after pro-
pranolol treatment as in the normal vessel of the untreated
group (Fig. 6). There was a significant increase in luminal
vessel area during exercise that was, however, slightly less
after propranolol treatment than in the untreated vessel dur-
ing maximal exercise. This might be due to reduced met-
abolic demands ("local" beta-blocking effect) although the
rate-pressure product was similar in both groups during ex-
ercise (14,500 versus 14,700 mm Hg/min). Sublingual
administration of 1.6 mg nitroglycerin at the end of the
exercise test further dilated normal coronary arteries with
or without propranolol pretreatment (Fig. 6). Administration
of intracoronary nitroglycerin before the exercise test caused
maximal vessel dilation with no further dilation during ex-
ercise, probably as a result of maximal vasodilation by ni-
troglycerin itself (Fig. 6).
Thus, the response of the normal coronary artery to ex-
ercise appears not to be affected by the administration of
intracoronary propranolol although vasodilation during
maximal exercise was slightly less (p = NS), probably
because of reduced metabolic demands after propranolol
pretreatment.
Stenotic coronary artery. The stenotic vessel showed
a completely different behavior during exercise compared
with the normal coronary artery. Without pretreatment the
stenotic coronary artery exhibited narrowing during exercise
(Fig. 7) with a decrease in stenotic luminal area of about
30%. This is because 70% of significant coronary stenoses
contain within their circumference (31) a normal vessel seg-
ment that has been shown to dilate or to narrow in response
to changes in perfusion pressure or pharmacologic inter-
ventions (32). The mechanism of exercise-induced coronary
stenosis narrowing is not clear but might be the result of
active vasoconstriction, passive collapse due to increased
coronary blood flow (Venturi mechanism) or thrombocyte
aggregation (5). Exercise-induced stenosis narrowing was
eliminated not only by intracoronary nitroglycerin but also
by intracoronary propranolol (Fig. 7).
Thus, exercise-induced vasoconstriction of the stenotic
coronary artery can be prevented by both drugs although
the mechanism seems to be completely different. Nitro-
glycerin is a potent coronary and venous vasodilator, whereas
propranolol acts as a negative inotropic agent with blockade
of the coronary beta-receptors (25,33).
Possible mode of action of intracoronary propranolol.
Theoretically, three different mechanisms could explain the
reaction of the stenotic coronary artery to intracoronary pro-
pranolol during dynamic exercise:
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I) Intracoronary administration of propranoloL Lowers
myocardial oxygen demand during exercise probably be-
cause of a "local" beta-blocking effect. This would lessen
the secondary autoregulatory rise in coronary flow and,
therefore, lessen the flow-dependent rise in transstenotic
pressure gradient. A lower transstenotic pressure gradient
during exercise would lessen the poststenotic drop in coro-
nary artery pressure and thus prevent the flow-induced fall
in stenosis distending pressure.
2) A second mechanism could be associated with a higher
vascular tone and a rise in distal coronary vascular re-
sistance due to unopposed distal arteriolaralpha-tone caused
by the "local" blockade of the beta-receptors. Unopposed
alpha-tone of the distal coronary vessel would result in a
higher poststenotic pressure and in a smaller transstenotic
pressuregradient with a higher stenosisdistendingpressure.
3) Propranolol has been shown in the isolated vessel
either to reduce (34,35) or to increase (36-39) coronary
artery diameter . The exact mechanism of either reaction is
not clear but seems to be related to the localanestheticeffect
of the drug with changes in coronary calcium influx. This
anesthetic effect is known to occur with propranolol but not
with atenolol (36). Differences in coronary vasomotion
however, seem, not to occur with different types of beta-
blocking agents, because each yields a good clinical re-
sponse in most patients with angina pectoris.
The possible role of these three mechanisms on coronary
stenosis during exercise cannot be estimated from our data.
However, our findings suggest that vasodilation of coronary
stenoses occurs during dynamic exercise, which would ex-
plain the good clinical response to propranolol treatment in
most patients with classical exercise-induced angina pec-
toris.
Role of pretreatment with intracoronary nitroglyc-
erin and propranolol. There might be even some additive
effect of intracoronary propranolol and sublingual nitro-
glycerin on the stenotic coronary artery (Fig. 6); stenotic
area increased by 45% after pretreatment with propranolol
and sublingual nitroglycerin and was significantly (p < 0.05)
largerthan the stenoticareaof thecontrol groupafter admin-
istration of sublingualnitroglycerin (+ 12%). However, this
might be due to patient selection and does not necessarily
represent a combined effect of the two drugs on coronary
stenosis. Although exercise-induced coronary stenosis nar-
rowing was eliminated by intracoronary propranolol and
nitroglycerin. angina pectoris still occurred during supine
bicycle exercise (Table I) and mean pulmonary artery pres-
sure rose significantly (Fig. 4). Mean aortic pressure re-
mained unchanged during exercise in patients pretreated
with intracoronary nitroglycerin or propranolol. The lack of
increase in aortic pressure can be explained by the occur-
rence of myocardial ischemia or the intracoronary admin-
istration of nitroglycerin or propranolol, or both. In the
control group, however, mean aortic pressure rose signifi-
cantly during exercise. The increase in mean pulmonary
artery pressure was also less in the propranolol and nitro-
glycerin groups than in the control group.
When the patients (propranolol and nitroglyceringroups)
were classified into patients with or without exercise-in-
duced angina pectoris, those with angina (n = 10) had a
significantly (p < 0.05) lower work load during supine
bicycle exercise (80 W) than did those without angina (n
= 6) (112 W). Despite the lower work load, the increase
in pulmonary artery pressure was similar (p = NS) in pa-
tients with (41 mm Hg) and without (31 mm Hg) exercise-
inducedangina. Normal and stenotic coronary luminal area
increased in both subgroups during exercise with no sig-
nificant difference betweenthe two. Thus, myocardial isch-
emia was more severe in patients with than in those without
exercise-induced angina. Nitroglycerin was, however, a more
potent drug than propranolol to decrease mean pulmonary
pressureduringexercise (Fig. 4). This mightbe due to either
less ischemia or reduced venous return. or both.
Effect of propranolol on coronary blood flow. Several
investigators (11,26) have discussed the effect of intrave-
nous administration of propranolol on coronary blood flow
in patientswithcoronaryarterydiseaseand exercise-induced
angina pectoris. Wolfson and Gorlin (26) found that pro-
pranolol produced a significant decrease in coronary flow.
They discussed the possibility of overall coronary vasocon-
striction induced by the administration of propranolol al-
though coronary artery diameter was not measured. Kern
et al. (II) reported a small decrease in coronary sinus blood
flow after intravenous injection of 0.1 mg/kg propranolol
during cold pressor testing. They concluded that beta-ad-
renergic blockade with propranolol potentiatedcoronary ar-
tery vasoconstriction, possibly mediated by unopposed al-
pha-adrenergic vasomotor tone, although coronary artery
diameter was not measured. Cold pressor testing is asso-
ciated with sympathetic stimulation, which is known to in-
duce coronary vasospasm in patients with coronary artery
disease and variant angina pectoris. Brown et al. (40) re-
centlydemonstrated coronary vasoconstriction of the normal
and the stenotic vessel segment during isometric exercise
(handgrip) by quantitativecoronary arteriography. They as-
sumed that isometric exercise may precipitate active vaso-
constriction by a reflex increase in circulating catechol-
amines with increasedsympatheticactivity. Thus, both cold
pressor testing and isometric handgrip exercise may induce
coronary vasoconstriction through increased alpha-adrener-
gic stimulation by circulating catecholamines (11,40). The
decrease in coronary blood flow after intravenous admin-
istrationof propranolol can be easily explained by secondary
effects on myocardial oxygen consumption such as a de-
crease in heart rate and contractility (8). Despite this de-
crease in blood flow, epicardial coronary vasomotor tone
does not necessarily change after propranolol administra-
tion.
JACC Vol. 10. No.2
August 1987:299-310
GAGLIONE ET AL
CORONARY VASOMOTION AFfER BETA-BLOCKADE
309
Limitations of the study. Quantitative coronary arte-
riography has been shown to be a reliable technique for
quantifying coronary artery stenoses (16). Interobserver var-
iability has been reported to be small and was 9% for mon-
oplane and 8% for biplane measurements in our study (Fig.
2). Because the analysis was performed in a blinded fashion
and repeated measurements of the same vessel segment
showed only small variations with an SO of 6 to 8%, this
technique seems to be accurate for detecting small differ-
ences in coronary lumen areas with a high reproducibility.
Measurements of a stainless steel rod showed excellent re-
sults with a measuring error between 0 and 1.5%. Thus,
quantitative coronary arteriography seems to be an appro-
priate technique for evaluating coronary artery stenoses at
rest and during exercise. However, this technique does not
allow one to quantitate coronary flow, which is not nec-
essarily related to vessel dimensions. The primary deter-
minants of coronary flow are the metabolic demands of the
myocardium, whereas coronary vasomotor tone has sepa-
rate, although interrelated, influences.
Clinical implications. Our previous observation (5) of
coronary stenosis narrowing during dynamic exercise led us
to study the effect of propranolol on coronary vasomotion.
We observed inhibition of coronary stenosis narrowing dur-
ing dynamic exercise after pretreatment with intracoronary
propranolol. The effect of propranolol appears to be limited
to the diseased vessel, because it did not influence the re-
sponse of the normal coronary vessel to exercise. Thus, the
efficacy of treatment of coronary artery disease by pro-
pranolol is due not solely to the reduction of myocardial
oxygen demand by changes in loading conditions and con-
tractility but also to vasodilation of the stenotic coronary
artery segments during exercise.
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